M. Lader

1.4k total citations
39 papers, 1.1k citations indexed

About

M. Lader is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, M. Lader has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in M. Lader's work include Epilepsy research and treatment (9 papers), Treatment of Major Depression (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). M. Lader is often cited by papers focused on Epilepsy research and treatment (9 papers), Treatment of Major Depression (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). M. Lader collaborates with scholars based in United Kingdom, Poland and United States. M. Lader's co-authors include J. P. R. Young, Stephen H. Curry, Hannes Pétursson, Jill A. Dalton, Isac Germano Karniol, G. Curzon, D.M. Hailey, Cosmo Hallström, R. N. Herrington and A.J. COLEMAN and has published in prestigious journals such as The Lancet, The British Journal of Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

M. Lader

39 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Lader United Kingdom	20	405	281	259	246	192	39	1.1k
Joseph Mendels United States	21	448 1.1×	373 1.3×	263 1.0×	533 2.2×	233 1.2×	33	1.5k
N Reisby Denmark	14	483 1.2×	296 1.1×	139 0.5×	520 2.1×	190 1.0×	27	1.1k
P.M.J. Haffmans Netherlands	20	455 1.1×	359 1.3×	203 0.8×	341 1.4×	178 0.9×	44	1.2k
Jay B. Cohn United States	17	481 1.2×	417 1.5×	177 0.7×	554 2.3×	151 0.8×	30	1.2k
J M Perel United States	21	433 1.1×	263 0.9×	195 0.8×	331 1.3×	220 1.1×	31	1.3k
H. E. Lehmann Canada	22	601 1.5×	169 0.6×	172 0.7×	305 1.2×	156 0.8×	100	1.5k
William F. Boyer United States	16	360 0.9×	300 1.1×	98 0.4×	432 1.8×	227 1.2×	27	1.0k
Burton J. Goldstein United States	14	233 0.6×	176 0.6×	97 0.4×	242 1.0×	198 1.0×	47	755
Stephen M. Stahl United States	20	562 1.4×	151 0.5×	332 1.3×	285 1.2×	289 1.5×	44	1.5k
Karl Rickels United States	14	379 0.9×	653 2.3×	189 0.7×	381 1.5×	167 0.9×	15	1.4k

Countries citing papers authored by M. Lader

Since Specialization

Citations

This map shows the geographic impact of M. Lader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lader more than expected).

Fields of papers citing papers by M. Lader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lader. The network helps show where M. Lader may publish in the future.

Co-authorship network of co-authors of M. Lader

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lader. A scholar is included among the top collaborators of M. Lader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lader. M. Lader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baldwin, David S., S.A. Montgomery, R. Nil, & M. Lader. (2005). Discontinuation symptoms in affective disorders. ePrints Soton (University of Southampton). 1 indexed citations

Curran, Valerie H., Susan E. Barrow, M. Lader, Márcio Bernik, & Herbert Weingartner. (1995). Encoding, remembering and awareness in lorazepam-induced amnesia. Psychopharmacology. 122(2). 187–193. 19 indexed citations

Lader, M. & R. N. Herrington. (1991). Biological Treatments in Psychiatry. International Clinical Psychopharmacology. 6(4). 239–239. 12 indexed citations

Higgitt, Anna, Peter Fonagy, & M. Lader. (1988). The natural history of tolerance to the benzodiazepines. PubMed. 13. 1–55. 26 indexed citations

Young, J. P. R., A.J. COLEMAN, & M. Lader. (1987). A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients. The British Journal of Psychiatry. 151(3). 337–340. 36 indexed citations

Lader, M., et al.. (1987). Subjective Effects During Administration and on Discontinuation of Zopiclone and Temazepam in Normal Subjects. Pharmacopsychiatry. 20(2). 67–71. 17 indexed citations

Roberts, Joanne E., Sylvia Checkley, John Crammer, et al.. (1986). A Case of Resistant Schizophrenia. The British Journal of Psychiatry. 149(6). 789–793. 4 indexed citations

Lader, M., et al.. (1985). CLINICAL MANAGEMENT OF BENZODIAZEPINE DEPENDENCE - REPLY. UCL Discovery (University College London). 3 indexed citations

Lader, M.. (1983). The psychophysiology of anxiety.. PubMed. 9(4 Suppl 2). 205B–210B. 95 indexed citations

10.

Lader, M., et al.. (1982). A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.. PubMed. 17 Suppl 2. 98–108. 6 indexed citations

11.

Pétursson, Hannes & M. Lader. (1981). Withdrawal reaction from clobazam.. BMJ. 282(6280). 1931–1932. 13 indexed citations

12.

Hallström, Cosmo & M. Lader. (1980). Diazepam and N‐desmethyldiazepam concentrations in saliva, plasma and CSF.. British Journal of Clinical Pharmacology. 9(4). 333–339. 33 indexed citations

13.

Young, J. P. R., et al.. (1979). Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.. BMJ. 2(6201). 1315–1317. 60 indexed citations

14.

Gentil, Valentim, B. Alevizos, & M. Lader. (1978). Effects of single doses of tranylcypromine on platelet mao and amine uptake in normal subjects. Biochemical Pharmacology. 27(8). 1197–1201. 4 indexed citations

15.

Lader, M.. (1976). Monitoring Plasma Concentrations of Neuroleptics^*. Pharmacopsychiatry. 9(4). 170–177. 26 indexed citations

16.

Lader, M.. (1975). Anxiety: its nature and treatment.. PubMed. 49(23). 939–43. 2 indexed citations

17.

Lader, M., et al.. (1975). The acute effects of oral (‐)‐tryptophan in human subjects.. British Journal of Clinical Pharmacology. 2(2). 165–172. 68 indexed citations

18.

Curry, Stephen H., et al.. (1972). Proceedings: Clinical pharmacology of chlorpromazine.. PubMed Central. 44(2). 370P–371P. 5 indexed citations

19.

Lader, M., et al.. (1971). Pharmacology of chlorpromazine: clinical studies.. PubMed. 41(2). 431P–431P. 2 indexed citations

20.

Lader, M.. (1970). The present status of psychotropic drugs. Pharmacological and clinical aspects. Journal of Psychosomatic Research. 14(2). 203–203. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact